Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
caspase 10 | 0.528 | 0.692 | 4.6E-12 |
|
group | 0.600 | None | 0 | 0 | |||||||||||
|
interferon regulatory factor 1 | 0.468 | 0.769 | 0.99 |
|
group | 0.600 | None | 0 | 0 | |||||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.700 | None | 1.000 | 3 | 0 | 1989 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.500 | None | 1.000 | 2 | 0 | 1991 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.360 | None | 1.000 | 2 | 0 | 1992 | 2013 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.640 | None | 1.000 | 0 | 0 | 1993 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.370 | None | 1.000 | 4 | 0 | 1995 | 2009 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.390 | None | 1.000 | 3 | 0 | 1995 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.450 | None | 1.000 | 1 | 0 | 1997 | 2008 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.600 | None | 1.000 | 6 | 0 | 1998 | 2017 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 1998 | 2008 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 4 | 0 | 1999 | 2012 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1999 | 2014 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.310 | None | 1.000 | 4 | 0 | 2000 | 2014 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.460 | None | 1.000 | 2 | 0 | 2000 | 2015 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2000 | 2015 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2015 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.520 | None | 1.000 | 1 | 0 | 2001 | 2015 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 2002 | 2016 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2015 | ||||||||
|
cytochrome P450 family 2 subfamily A member 6 | 0.556 | 0.731 | 5.4E-09 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2011 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2002 | 2008 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2004 | ||||||||
|
heparin binding EGF like growth factor | 0.520 | 0.769 | 7.6E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2005 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2002 | 2012 |